| 摘要 |
This invention relates to a novel class of substituted dihydroimidazo [1,2-a] quinoxaline derivatives of the formula …<CHEM>… wherein… R<1> is C1-C6 alkyl, benzyl, phenyl, a …<CHEM>… group, a ……(NH2-@-CH2)-… group or a ……(R<5>-@)-… group wherein R<4> is C1-C6 alkyl, and R<5> is C1-C8 alkyl, aminomethyl, pyridinyl, phenyl, halophenyl or a ……(R<6>-O-@-NHCH2)- group wherein R<6> is C1-C6 alkyl;… R<2> is phenyl or substituted phenyl having 1 or 2 substituents selected from the class consisting of halo or C1-C6 alkoxy;… R<3> is hydrogen or halogen; and… X is -CH- or -N-… and to pharmaceutical compositions containing such compounds. The compounds and compositions are effective as anti-anaerobic agents. |
